John A. Lewicki
2016
In 2016, John A. Lewicki earned a total compensation of $696K as Executive Vice President, Research and Development at OncoMed Pharmaceuticals, a 52% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $146,718 |
|---|---|
| Salary | $407,550 |
| Stock Awards | $141,750 |
| Total | $696,018 |
Lewicki received $407.6K in salary, accounting for 59% of the total pay in 2016.
Lewicki also received $146.7K in non-equity incentive plan and $141.8K in stock awards.
Rankings
In 2016, John A. Lewicki's compensation ranked 9,904th out of 14,075 executives tracked by ExecPay. In other words, Lewicki earned more than 29.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,904 out of 14,075 | 30th |
Division Manufacturing | 3,824 out of 5,489 | 30th |
Major group Chemicals And Allied Products | 1,337 out of 1,895 | 29th |
Industry group Drugs | 1,065 out of 1,538 | 31st |
Industry Pharmaceutical Preparations | 837 out of 1,176 | 29th |
Source: SEC filing on April 13, 2017.
Lewicki's colleagues
We found two more compensation records of executives who worked with John A. Lewicki at OncoMed Pharmaceuticals in 2016.